134
Participants
Start Date
October 31, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
November 30, 2009
exenatide
subcutaneous injection, 2.0mcg, once weekly
Research Site, Mesa
Research Site, Tempe
Research Site, Concord
Research Site, Fresno
Research Site, La Mesa
Research Site, Atlanta
Research Site, Idaho Falls
Research Site, Bowling Green
Research Site, Corvallis
Research Site, Chattanooga
Research Site, Memphis
Research Site, New Westminster
Research Site, Ajax
Research Site, Cambridge
Research Site, Windsor
Research Site, Chihuahua City
Research Site, Monterrey
Research Site, Distrito Federal
Research Site, Baia Mare
Research Site, Brasov
Research Site, Bucharesti
Research Site, Craiova
Research Site, Iași
Research Site, Suceava
Research Site, Johannesburg
Research Site, Pretoria
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY